Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH-a Effects on Angiogenesis in Endometriosis
NCT06106932Completed
- Sponsor
- University of Patras
- Start
- Sep 2015
- Primary completion
- Jan 2023
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
Randomised, open-label trial of leuprolide in endometriosis (2 arms), sponsored by University of Patras. Primary endpoints: Vascular Endothelial Growth Factor mRNA expression at 3 months, Tissue Factor mRNA expression at 3 months and 2 more. Started Sep 2015; status: completed.
02
Drugs
leuprolide
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT06106932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06106932.